BMED ETF largest holding is MRK at 5.76% as of Aug 5, 2026
iShares Health Innovation Active ETF
MRK is BMED's largest holding at 5.76% of the fund as of Aug 5, 2026. BMED is iShares Health Innovation Active ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 |  M | Merck & Company IncHealth Care · Pharmaceuticals | 5.76% | 5.8% | 5,064 | $649.9K | Health Care | Pharmaceuticals |
| 2 |  G | Gilead SciencesHealth Care · Pharmaceuticals | 4.86% | 10.6% | 4,165 | $548.8K | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 |  E | Edwards Lifesciences Corp | 4.51% | 15.1% | 5,726 | $509.4K | ||
| 4 |  J | Johnson & Johnson - | 4.46% | 19.6% | 1,955 | $503.6K | ||
| 5 | Debt | Blackrock Cash Funds: Treasury, Sl Agency Shares | 4.34% | 23.9% | 490,000 | $490.0K | ||
| 6 |  T | Thermo Fisherscientific Inc. | 4.16% | 28.1% | 812 | $469.2K | ||
| 7 |  C | Charles River Laboratories International Inc | 4.12% | 32.2% | 1,783 | $464.9K | ||
| 8 |  D | Danaher Corp | 3.67% | 35.9% | 2,077 | $414.7K | ||
| 9 |  W | Waters Corp. | 3.67% | 39.6% | 1,035 | $414.0K | ||
| 10 |  B | Biogen Inc. | 3.54% | 43.1% | 1,935 | $399.8K | ||
| 11 |  M | Mettler-Toledo International Inc. | 3.45% | 46.5% | 274 | $389.5K | ||
| 12 |  A | AbbVie Inc. | 3.33% | 49.9% | 1,528 | $376.2K | ||
| 13 | — | Moderna therapeutics | 2.97% | 52.8% | 5,948 | $334.6K | ||
| 14 | — | Nvaesrtex Pharmaceuticals Inc | 2.96% | 55.8% | 690 | $334.5K | ||
| 15 |  A | Amgen Inc. | 2.61% | 58.4% | 722 | $294.5K | ||
| 16 |  D | Dexcom Inc. | 2.56% | 61.0% | 3,493 | $288.7K | ||
| 17 |  T | Bio-Techne Corp | 2.43% | 63.4% | 3,805 | $274.0K | ||
| 18 |  I | Illumina, Inc. | 2.32% | 65.7% | 1,309 | $261.6K | ||
| 19 | — | Novartis Ag Sponsored Adr (1 Ads : 1 Ordinary) | 2.16% | 67.9% | 1,579 | $243.6K | ||
| 20 |  R | Roper Technologies Inc. | 2.16% | 70.0% | 540 | $244.1K | ||
| 21 |  I | Incyte Corp. | 2.10% | 72.1% | 1,981 | $237.3K | ||
| 22 |  I | Iqvia Holdings Inc | 1.94% | 74.1% | 929 | $219.3K | ||
| 23 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | 1.92% | 76.0% | 250 | $217.0K | ||
| 24 |  C | Cytokinetics Inc | 1.82% | 77.8% | 2,600 | $205.0K | ||
| 25 |  A | Abbott Laboratories | 1.68% | 79.5% | 1,797 | $190.0K | ||
| 26 |  N | Neurocrine Biosciences Inc | 1.64% | 81.1% | 1,145 | $184.9K | ||
| 27 |  G | Guardant Health, Inc | 1.52% | 82.7% | 1,050 | $171.3K | ||
| 28 | — | Roivant Sciences Ltd. Common Shares | 1.43% | 84.1% | 4,654 | $161.0K | ||
| 29 |  R | Revolution Medicines Inc | 1.26% | 85.3% | 723 | $142.6K | ||
| 30 |  H | Halozyme Therapeutics Inc | 1.24% | 86.6% | 1,680 | $140.4K | ||
| 31 |  A | Axsome Therapeutics Inc | 1.22% | 87.8% | 649 | $138.1K | ||
| 32 |  B | Bristol-Myers Squibb Co. | 1.22% | 89.0% | 2,169 | $138.0K | ||
| 33 | — | Wuxi Biologics (cayman) Inc. | 1.22% | 90.2% | 26,500 | $137.2K | ||
| 34 |  B | Biomarin Pharmaceutical Inc. | 1.21% | 91.5% | 2,280 | $136.6K | ||
| 35 |  P | Protagonist Therapeutics Inc | 0.95% | 92.4% | 780 | $107.1K | ||
| 36 |  B | Bruker Corp. | 0.86% | 93.3% | 1,844 | $96.8K | ||
| 37 | — | Ucb Sa | 0.78% | 94.0% | 333 | $88.2K | ||
| 38 | — | Alkermes Plc. Ordinary Shares | 0.75% | 94.8% | 1,712 | $84.9K | ||
| 39 |  A | Apogee Therapeutics Inc | 0.69% | 95.5% | 576 | $77.3K | ||
| 40 |  D | Dianthus Therapeutics Inc | 0.65% | 96.1% | 651 | $73.2K | ||
| 41 |  R | Arcus Biosciences Inc | 0.63% | 96.8% | 2,566 | $71.1K | ||
| 42 |  C | Cogent Biosciences Inc | 0.61% | 97.4% | 1,632 | $69.0K | ||
| 43 |  M | Mbx Biosciences Inc | 0.59% | 98.0% | 993 | $67.0K | ||
| 44 | — | Biontech Se Adr | 0.58% | 98.5% | 705 | $65.0K | ||
| 45 |  I | Insmed Inc | 0.43% | 99.0% | 493 | $48.8K | ||
| 46 |  E | Erasca Inc. | 0.39% | 99.4% | 2,375 | $44.2K | ||
| 47 |  A | Avalo Therapeuti | 0.13% | 99.5% | 781 | $14.7K | ||
| 48 |  S | Sagimet Biosciences Inc | 0.13% | 99.6% | 1,688 | $14.6K | ||
| 49 |  E | Eikon Therapeutics Inc | 0.11% | 99.7% | 1,253 | $12.0K | ||
| 50 |  R | Ultragenyx Pharmaceutical Inc | 0.10% | 99.8% | 460 | $11.5K | ||
| More holdings · Pro | ||||||||
BMED ETF All Holdings
BMED holdings total 61 positions. The top 10 holdings account for 43.1% of the fund, led by Merck & Company Inc at 5.8%, Gilead Sciences at 4.9%, Edwards Lifesciences Corp at 4.5%.
BMED portfolio concentration is moderate, with the top 10 representing 43.1% of total assets. The largest sector exposure is Health Care at 91.2%.
BMED sectors provide a detailed breakdown. BMED overlap shows how holdings compare to other funds in your portfolio.
BMED ETF Holdings
60 of 61 holdings
- 1
Merck & Company Inc
MRKHealth Care5.76% - 2
Gilead Sciences
GILDHealth Care4.86% - 3
Edwards Lifesciences Corp
EWHealth Care4.51% - 4
Johnson & Johnson - Common
JNJHealth Care4.46% - 5
Blackrock Cash Funds: Treasury, Sl Agency Shares
XTSLAFinancials4.34% - 6
Thermo Fisherscientific Inc.
TMOHealth Care4.16% - 7
Charles River Laboratories International Inc
CRLHealth Care4.12% - 8
Danaher Corporation
DHRHealth Care3.67% - 9
Waters Corp.
WATHealth Care3.67% - 10
Biogen Inc. Com
BIIBHealth Care3.54% - 11
Mettler-Toledo International Inc.
MTDHealth Care3.45% - 12
Abbvie Inc.
ABBVHealth Care3.33% - 13
Moderna therapeutics
MRNAHealth Care2.97% - 14
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care2.96% - 15
Amgen Inc.
AMGNHealth Care2.61% - 16
Dexcom Inc.
DXCMHealth Care2.56% - 17
Bio-Techne Corp
TECHHealth Care2.43% - 18
Illumina, Inc.
ILMNHealth Care2.32% - 19
Novartis Ag Sponsored Adr (1 Ads : 1 Ordinary)
NVS:SMHealth Care2.16% - 20
Roper Technologies Inc.
ROPIndustrials2.16% - 21
Incyte Corp.
INCYHealth Care2.10% - 22
Iqvia Holdings Inc
IQVHealth Care1.94% - 23
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care1.92% - 24
Cytokinetics Inc
CYTKHealth Care1.82% - 25
Abbott Laboratories
ABTHealth Care1.68% - 26
Neurocrine Biosciences Inc
NBIXHealth Care1.64% - 27
Guardant Health, Inc
GHHealth Care1.52% - 28
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care1.43% - 29
Revolution Medicines Inc
RVMDHealth Care1.26% - 30
Halozyme Therapeutics Inc
HALOHealth Care1.24% - 31
Axsome Therapeutics Inc
AXSMHealth Care1.22% - 32
Bristol-Myers Squibb Co.
BMYHealth Care1.22% - 33
Wuxi Biologics (cayman) Inc.
2269:HKUnknown1.22% - 34
Biomarin Pharmaceutical Inc.
BMRNHealth Care1.21% - 35
Protagonist Therapeutics Inc
PTGXHealth Care0.95% - 36
Bruker Corp.
BRKRInformation Technology0.86% - 37
Ucb Sa
UCB:BRHealth Care0.78% - 38
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care0.75% - 39
Apogee Therapeutics Inc
APGEHealth Care0.69% - 40
Dianthus Therapeutics Inc
DNTHHealth Care0.65% - 41
Arcus Biosciences Inc
RCUSHealth Care0.63% - 42
Cogent Biosciences Inc
COGTHealth Care0.61% - 43
Mbx Biosciences Inc
MBXHealth Care0.59% - 44
Biontech Se Adr
BNTX:FFHealth Care0.58% - 45
Insmed Inc
INSMHealth Care0.43% - 46
Erasca Inc.
ERASHealth Care0.39% - 47
Avalo Therapeuti
AVTXHealth Care0.13% - 48
Sagimet Biosciences Inc
SGMTHealth Care0.13% - 49
Eikon Therapeutics Inc
EIKNUnknown0.11% - 50
Ultragenyx Pharmaceutical Inc
RAREHealth Care0.10% - 51
Summit Therapeutics Inccommon Stock
SMMTHealth Care0.08% - 52
Mastrn 5.000 06/01/52
Other0.05% - 53
Contra Abiomed Inc
ABMDHealth Care0.00% - 54
Contra Blueprint Medic
Health Care0.00% - 55
Mirati Therapeutics Inc
MRTXUnknown0.00% - 56
Contra Vigil Neuroscie Common Stock
Other0.00% - 57
Fswp: Ois Recfix USD 3.6475% 02-27-26/02-27-28 Lch
Other0.00% - 58
Bought Egp Sold USD 20260420
Other0.00% - 59
Virginia Revenue Bonds West Falls Community Development Authority 5.375 09/01/2052
Other0.00% - 60
USD/CHF Forward
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Merck & Company Inc | MRK | 5.760% | ||
| 2 | Gilead Sciences | GILD | 4.860% | ||
| 3 | Edwards Lifesciences Corp | EW | 4.510% | ||
| 4 | Johnson & Johnson - Common | JNJ | 4.460% | ||
| 5 | Blackrock Cash Funds: Treasury, Sl Agency Shares | XTSLA | 4.340% | ||
| 6 | Thermo Fisherscientific Inc. | TMO | 4.160% | ||
| 7 | Charles River Laboratories International Inc | CRL | 4.120% | ||
| 8 | Danaher Corporation | DHR | 3.670% | ||
| 9 | Waters Corp. | WAT | 3.670% | ||
| 10 | Biogen Inc. Com | BIIB | 3.540% | ||
| 11 | Mettler-Toledo International Inc. | MTD | 3.450% | ||
| 12 | Abbvie Inc. | ABBV | 3.330% | ||
| 13 | Moderna therapeutics | MRNA | 2.970% | ||
| 14 | Nvaesrtex Pharmaceuticals Inc | VRTX | 2.960% | ||
| 15 | Amgen Inc. | AMGN | 2.610% | ||
| 16 | Dexcom Inc. | DXCM | 2.560% | ||
| 17 | Bio-Techne Corp | TECH | 2.430% | ||
| 18 | Illumina, Inc. | ILMN | 2.320% | ||
| 19 | Novartis Ag Sponsored Adr (1 Ads : 1 Ordinary) | NVS:SM | 2.160% | ||
| 20 | Roper Technologies Inc. | ROP | 2.160% | ||
| 21 | Incyte Corp. | INCY | 2.100% | ||
| 22 | Iqvia Holdings Inc | IQV | 1.940% | ||
| 23 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 1.920% | ||
| 24 | Cytokinetics Inc | CYTK | 1.820% | ||
| 25 | Abbott Laboratories | ABT | 1.680% | ||
| 26 | Neurocrine Biosciences Inc | NBIX | 1.640% | ||
| 27 | Guardant Health, Inc | GH | 1.520% | ||
| 28 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 1.430% | ||
| 29 | Revolution Medicines Inc | RVMD | 1.260% | ||
| 30 | Halozyme Therapeutics Inc | HALO | 1.240% | ||
| 31 | Axsome Therapeutics Inc | AXSM | 1.220% | ||
| 32 | Bristol-Myers Squibb Co. | BMY | 1.220% | ||
| 33 | Wuxi Biologics (cayman) Inc. | 2269:HK | 1.220% | ||
| 34 | Biomarin Pharmaceutical Inc. | BMRN | 1.210% | ||
| 35 | Protagonist Therapeutics Inc | PTGX | 0.950% | ||
| 36 | Bruker Corp. | BRKR | 0.860% | ||
| 37 | Ucb Sa | UCB:BR | 0.780% | ||
| 38 | Alkermes Plc. Ordinary Shares | ALKS:IE | 0.750% | ||
| 39 | Apogee Therapeutics Inc | APGE | 0.690% | ||
| 40 | Dianthus Therapeutics Inc | DNTH | 0.650% | ||
| 41 | Arcus Biosciences Inc | RCUS | 0.630% | ||
| 42 | Cogent Biosciences Inc | COGT | 0.610% | ||
| 43 | Mbx Biosciences Inc | MBX | 0.590% | ||
| 44 | Biontech Se Adr | BNTX:FF | 0.580% | ||
| 45 | Insmed Inc | INSM | 0.430% | ||
| 46 | Erasca Inc. | ERAS | 0.390% | ||
| 47 | Avalo Therapeuti | AVTX | 0.130% | ||
| 48 | Sagimet Biosciences Inc | SGMT | 0.130% | ||
| 49 | Eikon Therapeutics Inc | EIKN | 0.110% | ||
| 50 | Ultragenyx Pharmaceutical Inc | RARE | 0.100% | ||
| 51 | Summit Therapeutics Inccommon Stock | SMMT | 0.080% | ||
| 52 | Mastrn 5.000 06/01/52 | - | 0.050% | ||
| 53 | Contra Abiomed Inc | ABMD | 0.000% | ||
| 54 | Contra Blueprint Medic | - | 0.000% | ||
| 55 | Mirati Therapeutics Inc | MRTX | 0.000% | ||
| 56 | Contra Vigil Neuroscie Common Stock | - | 0.000% | ||
| 57 | Fswp: Ois Recfix USD 3.6475% 02-27-26/02-27-28 Lch | - | 0.000% | ||
| 58 | Bought Egp Sold USD 20260420 | - | 0.000% | ||
| 59 | Virginia Revenue Bonds West Falls Community Development Authority 5.375 09/01/2052 | - | 0.000% | ||
| 60 | USD/CHF Forward | - | 0.000% |